" class="no-js "lang="en-US"> Codagenix Archives - Medtech Alert
Wednesday, May 31, 2023

Breaking News

Cumulus Neuroscience Completes Patient Enrollment for Pivotal CNS-101 Early-Stage Alzheimer’s Dementia Validation Trial Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts Mission Bio Launches Tapestri v3 to Rapidly Accelerate Rare Cell Detection Applications for Translational Research and Precision Therapeutics Ostentus Therapeutics and City of Hope to Continue Studies of Novel OST Natural Products for Treatment of Leukemia and Other Cancers Cellular Origins launches Constellation, its Configurable Robotic Platform to Enable Scalable Manufacture of Advanced Therapies Historic Milestone: UK Patients Receive First CannEpil® Delivery through ‘I AM Billy Foundation’ and GMC Specialist Register CANbridge Announces Full Enrollment Reached in China Region of the Global LIVMARLI® (CAN108) EMBARK Phase 2 Study in Biliary Atresia Juha Punnonen, M.D., Ph.D. Joins Hinge Bio as Chief Development Officer SNIPR Biome Reports Positive Clinical Interim Results for Groundbreaking, First-in-Human, CRISPR-based Microbial Gene Therapy Pfizer Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B Trial

Sort by:

Date

Top Post

SNIPR Biome Reports Positive Clinical Interim Results for Groundbreaking, First-in-Human, CRISPR-based Microbial Gene Therapy | MTA

SNIPR Biome Reports Positive Clinical Interim Results for Groundbreaking, First-in-Human, CRISPR-based Microbial Gene Therapy

SNIPR Biome, the company pioneering CRISPR microbial gene therapy, has announced positive interim clinical results […]

Read more

COVID-19

 Intranasal COVID-19 Vaccine Demonstrates Single-dose Efficacy in Preclinical Studies

Intranasal COVID-19 Vaccine Demonstrates Single-dose Efficacy in Preclinical Studies, in Parallel with Achievement of Phase 1 Clinical Milestone

Codagenix Inc., a clinical-stage synthetic biology company pioneering a novel platform for vaccines and oncolytic […]

  1. Cumulus Neuroscience Completes Patient Enrollment for Pivotal CNS-101 Early-Stage Alzheimer’s Dementia Validation Trial

    Clinical Trials

     Read more
  2. Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts

    Appointments

     Read more
  3. Mission Bio Launches Tapestri v3 to Rapidly Accelerate Rare Cell Detection Applications for Translational Research and Precision Therapeutics

    Gene Therapy

     Read more
  4. Ostentus Therapeutics and City of Hope to Continue Studies of Novel OST Natural Products for Treatment of Leukemia and Other Cancers

    News

     Read more
  5. Cellular Origins launches Constellation, its Configurable Robotic Platform to Enable Scalable Manufacture of Advanced Therapies

    Drug Development

     Read more